Live Breaking News & Updates on Akt Inhibitors

Stay updated with breaking news from Akt inhibitors. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

HR+/HER2- Breast Cancer: Inhibiting the PI3K/AKT/mTOR Pathway

Dr Vidal expands on use of PI3K/AKT/mTOR pathway inhibitors following frontline progression, focusing on the PI3K inhibitor alpelisib for patients with PIK3CA mutations, as well as capivasertib, an AKT inhibitor in development. ....

Aditya Bardia , Gregory Vidal , Komal Jhaveri , Hr Her2 Breast Cancer , Cdk4 6 Inhibitors , Second Line Therapies , Endocrine Therapy , Endocrine Resistance , Akt Inhibitors , Capitello 291 , Maintain Trial , Ember 3 , Oral Serds , Viktoria 1 ,

Innovation in cancer research showcased at Markey Research Day

A day-long spotlight event May 12 highlighted the latest advancements in cancer research underway at the University of Kentucky Markey Cancer Center. ....

United Kingdom , Krystle Kuhs , Kristen Hill , Mark Evers , Vilma Bursac , Nan Lin , Jing Yan , Cullin Neddylation , Christine Brainson , Marvellae Ford , Caitlin Miller , Fengyi Mao , Tianyan Gao , Jessica Thompson , Lois Reynolds , Taylor Rives , Edward Chu , Anastasia Lyon , Tara Kadayat , James Knight , Susanb Lester , Xiaoyue Yang , Gilberth Friedell , Rina Plattner , Louis Rodgers , A Community ,